KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Resmed (RMD) Interest Expenses (2016 - 2022)

Resmed's Interest Expenses history spans 7 years, with the latest figure at $5.5 million for Q1 2022.

  • For Q1 2022, Interest Expenses fell 6.2% year-over-year to $5.5 million; the TTM value through Dec 2022 reached $5.5 million, down 76.02%, while the annual FY2021 figure was $24.0 million, 40.59% down from the prior year.
  • Interest Expenses reached $5.5 million in Q1 2022 per RMD's latest filing, down from $5.9 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $12.5 million in Q2 2019 to a low of $3.7 million in Q3 2018.
  • Average Interest Expenses over 5 years is $7.7 million, with a median of $6.7 million recorded in 2020.
  • Peak YoY movement for Interest Expenses: plummeted 52.37% in 2018, then surged 196.44% in 2019.
  • A 5-year view of Interest Expenses shows it stood at $7.5 million in 2018, then surged by 36.5% to $10.2 million in 2019, then tumbled by 43.33% to $5.8 million in 2020, then increased by 2.69% to $5.9 million in 2021, then dropped by 8.17% to $5.5 million in 2022.
  • Per Business Quant, the three most recent readings for RMD's Interest Expenses are $5.5 million (Q1 2022), $5.9 million (Q4 2021), and $5.4 million (Q3 2021).